Immunostaining for MECP2 and pH2AX provided compelling evidence of elevated DNA damage in the absence of MECP2 (Fig. 7C,D), as was shown in the brains of patients with RTT (Fig. 4). This evidence concerns the gene MECP2 and Rett syndrome.